No two launches are the same, particularly when launching originator medicines and biosimilars across diverse global markets. This session will explore how launch excellence teams can develop flexible launch archetypes that balance the goals of global teams with local market needs to maximise launch success for originator drugs and biosimilars alike.
Check out the incredible speaker line-up to see who will be joining Oksana.
Download The Latest Agenda